Extraordinary diseases require extraordinary solutions-Reference-Cited by-同舟云学术

Extraordinary diseases require extraordinary solutions

Published:2020-05 Issue:24 Volume:38 Page:3987-3988
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Plotkin Stanley A.,Caplan Arthur

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference8 articles.

1. The complexity and cost of vaccine manufacturing - An overview;Plotkin;Vaccine,2017

2. Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!);Henao-Restrepo;Lancet,2017

3. The 1918 influenza pandemic and its legacy;Taubenberger;Cold Spring Harb Perspect Med,2019

4. Eyal N, Lipsitch M, Smith PG. Human challenge studies to accelerate coronavirus vaccine licensure. Preprint at DASH http://nrs.harvard.edu/urn-3:HUL.InstRepos:42639016 (March 24, 2020).

5. The future of flu: a review of the human challenge model and systems biology for advanceent of influenza vaccinology;Sherman;Front Cell Infect Microbiol,2019

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benefits of Combining Molecular Biology and Controlled Human Infection Model Methodologies in Advancing Vaccine Development;Journal of Molecular Biology;2023-12

2. Bioinformatic investigation of Nipah virus surface protein mutations: Molecular docking with Ephrin B2 receptor, molecular dynamics simulation, and structural impact analysis;Microbiology and Immunology;2023-10-09

3. The Case for Human Challenge Trials in COVID-19;Journal of Bioethical Inquiry;2023-09-18

4. Sobre la obligatoriedad de las vacunas en tiempos de covid-19: aproximación contextual y análisis desde el Derecho y las políticas comparadas;Relaciones Internacionales;2023-02-27

5. Ethics;Plotkin's Vaccines;2023